These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17532462)

  • 1. 11beta-Hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia.
    Causevic M; Mohaupt M
    Mol Aspects Med; 2007 Apr; 28(2):220-6. PubMed ID: 17532462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
    Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular ATP determines 11beta-hydroxysteroid dehydrogenase type 2 activity via purinergic receptors.
    Kadereit B; Fustier P; Shojaati K; Frey BM; Frey FJ; Mohaupt MG
    J Am Soc Nephrol; 2005 Dec; 16(12):3507-16. PubMed ID: 16251242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pro-inflammatory cytokines on expression and activity of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human term placental trophoblast and human choriocarcinoma JEG-3 cells.
    Chisaka H; Johnstone JF; Premyslova M; Manduch Z; Challis JR
    J Soc Gynecol Investig; 2005 Jul; 12(5):303-9. PubMed ID: 15979541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory cytokines inhibit human placental 11beta-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways.
    Kossintseva I; Wong S; Johnstone E; Guilbert L; Olson DM; Mitchell BF
    Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E282-8. PubMed ID: 16174654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
    Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
    Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia.
    Schoof E; Girstl M; Frobenius W; Kirschbaum M; Dörr HG; Rascher W; Dötsch J
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1313-7. PubMed ID: 11238526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia blocks 11beta-hydroxysteroid dehydrogenase type 2 induction in human trophoblast cells during differentiation by a time-dependent mechanism that involves both translation and transcription.
    Homan A; Guan H; Hardy DB; Gratton RJ; Yang K
    Placenta; 2006 Aug; 27(8):832-40. PubMed ID: 16271275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
    Draper N; Stewart PM
    J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interconversion of cortisol and cortisone by 11beta-hydroxysteroid dehydrogenases type 1 and 2 in the perfused human placenta.
    Sun K; Adamson SL; Yang K; Challis JR
    Placenta; 1999 Jan; 20(1):13-9. PubMed ID: 9950140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
    Ricketts ML; Stewart PM
    Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation.
    Rabbitt EH; Lavery GG; Walker EA; Cooper MS; Stewart PM; Hewison M
    FASEB J; 2002 Jan; 16(1):36-44. PubMed ID: 11772934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
    J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR
    Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates.
    Struwe E; Berzl GM; Schild RL; Beckmann MW; Dörr HG; Rascher W; Dötsch J
    Am J Obstet Gynecol; 2007 Jul; 197(1):43.e1-6. PubMed ID: 17618751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the plasma half-life of 11alpha-deuterium cortisol as a sensitive index for the analysis of human 11beta-HSD2 activity in vivo.
    Kasuya Y; Yokokawa A; Hamura K; Shibasaki H; Furuta T
    Steroids; 2005 Nov; 70(12):811-6. PubMed ID: 16005482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors.
    Lanz B; Kadereit B; Ernst S; Shojaati K; Causevic M; Frey BM; Frey FJ; Mohaupt MG
    Kidney Int; 2003 Sep; 64(3):970-7. PubMed ID: 12911547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
    Stegk JP; Ebert B; Martin HJ; Maser E
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):104-8. PubMed ID: 19022342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.